We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WALMEX:BMVWal-Mart de Mexico SAB de CV Analysis

Data as of 2026-07-31 - not real-time

MX$50.19

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Wal‑Mart de México is trading below its short‑term moving averages, with the current price sitting under the 20‑day and 50‑day SMAs, while the 200‑day SMA remains well above the market level, indicating a bearish technical backdrop. Momentum signals are mixed: the RSI hovers around the neutral zone and the MACD histogram has turned positive, suggesting a tentative bullish tilt, yet volume is on a downtrend and the broader trend direction is still classified as bearish. The stock offers an attractive dividend yield and a payout ratio that remains comfortably below the typical sustainability threshold, supported by solid operating and free cash flow generation. However, the DCF‑derived fair value is substantially lower than the market price, and recent analyst revisions have trimmed price targets in response to softer consumption trends, adding a layer of valuation pressure.
Given the defensive nature of the consumer‑discretionary segment, low beta, and consistent cash generation, the company retains a stable long‑run profile, but short‑term price action is likely to be constrained by technical weakness and muted demand outlook. Investors should weigh the high dividend income against the overvaluation relative to intrinsic estimates and the bearish technical signals when deciding on positioning.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below short‑term moving averages
  • decreasing volume trend
  • analyst target reductions reflecting softer consumption

Medium Term

1–3 years
Neutral
Model confidence: 8/10

Key Factors

  • stable dividend yield and cash flow generation
  • defensive sector positioning
  • ongoing valuation gap between market price and intrinsic estimates

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • strong return on equity and consistent profitability
  • low beta indicating limited market volatility exposure
  • sustained dividend policy supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin4.90%
P/E Ratio17.4
ROE21.92%
ROA9.87%
Debt/Equity34.83
P/B Ratio3.6
Op. Cash FlowMX$88.6B
Free Cash FlowMX$22.5B

Technical Analysis

TrendBearish
RSI53.4
SupportMX$46.61
ResistanceMX$50.86
MA 20MX$49.22
MA 50MX$50.80
MA 200MX$56.23
MACDBullish
VolumeDecreasing
Fear & Greed Index90.91

Valuation

Fair ValueMX$15.04
Target PriceMX$61.43
Upside/Downside22.39%
GradeOvervalued
TypeValue
Dividend Yield4.06%

Risk Assessment

Beta0.24
Volatility18.84%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.